222 related articles for article (PubMed ID: 25027673)
1. Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model.
Rahnama M; Mahmoudi M; Zamani Taghizadeh Rabe S; Balali-Mood M; Karimi G; Tabasi N; Riahi-Zanjani B
J Immunotoxicol; 2015; 12(3):231-8. PubMed ID: 25027673
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of anti-tumor effects of tumor cell lysate enriched by HSP-70 against fibrosarcoma tumor in BALB/c mice.
Hashemi SM; Hassan ZM; Soudi S; Ghazanfari T; Kheirandish M; Shahabi S
Int Immunopharmacol; 2007 Jul; 7(7):920-7. PubMed ID: 17499194
[TBL] [Abstract][Full Text] [Related]
3. Naloxone can improve the anti-tumor immunity by reducing the CD4+CD25+Foxp3+ regulatory T cells in BALB/c mice.
Molla Hassan AT; Hassan ZM; Moazzeni SM; Mostafaie A; Shahabi S; Ebtekar M; Hashemi SM
Int Immunopharmacol; 2009 Nov; 9(12):1381-6. PubMed ID: 19706340
[TBL] [Abstract][Full Text] [Related]
4. Arteether exerts antitumor activity and reduces CD4+CD25+FOXP3+ T-reg cells in vivo.
Azimi Mohamadabadi M; Hassan ZM; Zavaran Hosseini A; Gholamzad M; Noori S; Mahdavi M; Maroof H
Iran J Immunol; 2013 Sep; 10(3):139-49. PubMed ID: 24076591
[TBL] [Abstract][Full Text] [Related]
5. Long acting propranolol and HSP-70 rich tumor lysate reduce tumor growth and enhance immune response against fibrosarcoma in Balb/c mice.
Khalili A; Hassan ZM; Shahabi S; Pourfathollah AA; Ostad SN; Noori S; Mahdavi M; Haybar H; Langroudi L
Iran J Immunol; 2013 Jun; 10(2):70-82. PubMed ID: 23811546
[TBL] [Abstract][Full Text] [Related]
6. Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate.
Suszko A; Obmińska-Mrukowicz B
J Ethnopharmacol; 2013 Jan; 145(1):109-17. PubMed ID: 23123796
[TBL] [Abstract][Full Text] [Related]
7. IL-7 inhibits tumor growth by promoting T cell-mediated antitumor immunity in Meth A model.
Tang JC; Shen GB; Wang SM; Wan YS; Wei YQ
Immunol Lett; 2014; 158(1-2):159-66. PubMed ID: 24406503
[TBL] [Abstract][Full Text] [Related]
8. iNOS expression in CD4+ T cells limits Treg induction by repressing TGFβ1: combined iNOS inhibition and Treg depletion unmask endogenous antitumor immunity.
Jayaraman P; Alfarano MG; Svider PF; Parikh F; Lu G; Kidwai S; Xiong H; Sikora AG
Clin Cancer Res; 2014 Dec; 20(24):6439-51. PubMed ID: 25278453
[TBL] [Abstract][Full Text] [Related]
9. Improvement of antitumor effect of intratumoral injection of immature dendritic cells into irradiated tumor by cyclophosphamide in mouse colon cancer model.
Son CH; Shin DY; Kim SD; Park HS; Jung MH; Bae JH; Kang CD; Yang K; Park YS
J Immunother; 2012 Oct; 35(8):607-14. PubMed ID: 22996366
[TBL] [Abstract][Full Text] [Related]
10. Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo.
Farsam V; Hassan ZM; Zavaran-Hosseini A; Noori S; Mahdavi M; Ranjbar M
Int Immunopharmacol; 2011 Nov; 11(11):1802-8. PubMed ID: 21824530
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific crosslinking of GITR as costimulation for immunotherapy.
Burckhart T; Thiel M; Nishikawa H; Wüest T; Müller D; Zippelius A; Ritter G; Old L; Shiku H; Renner C
J Immunother; 2010; 33(9):925-34. PubMed ID: 20948444
[TBL] [Abstract][Full Text] [Related]
12. Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals.
Mitsui J; Nishikawa H; Muraoka D; Wang L; Noguchi T; Sato E; Kondo S; Allison JP; Sakaguchi S; Old LJ; Kato T; Shiku H
Clin Cancer Res; 2010 May; 16(10):2781-91. PubMed ID: 20460483
[TBL] [Abstract][Full Text] [Related]
13. Myeloid suppressor cell-associated immune dysfunction in CSA1M fibrosarcoma tumor-bearing mice.
Zhou R; He PL; Ren YX; Wang WH; Zhou RY; Wan H; Ono S; Fujiwara H; Zuo JP
Cancer Sci; 2007 Jun; 98(6):882-9. PubMed ID: 17433038
[TBL] [Abstract][Full Text] [Related]
14. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
[TBL] [Abstract][Full Text] [Related]
15. Sclareol reduces CD4+ CD25+ FoxP3+ Treg cells in a breast cancer model in vivo.
Noori S; Hassan ZM; Salehian O
Iran J Immunol; 2013 Mar; 10(1):10-21. PubMed ID: 23502334
[TBL] [Abstract][Full Text] [Related]
16. Effect of aged garlic extract on immune responses to experimental fibrosarcoma tumor in BALB/c mice.
Tabari MA; Ebrahimpour S
Indian J Cancer; 2014; 51(4):609-13. PubMed ID: 26842212
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells.
Yang Y; Paik JH; Cho D; Cho JA; Kim CW
Int Immunopharmacol; 2008 Apr; 8(4):542-7. PubMed ID: 18328445
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with tumor cell lysate-pulsed CD8α+ dendritic cells modulates intra-tumor and spleen lymphocyte subpopulations.
Azadmehr A; Pourfathollah AA; Amirghofran Z; Hassan ZM; Moazzeni SM
Neoplasma; 2013; 60(5):525-32. PubMed ID: 23790171
[TBL] [Abstract][Full Text] [Related]
19. Depletion of CD4+CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma.
Imai H; Saio M; Nonaka K; Suwa T; Umemura N; Ouyang GF; Nakagawa J; Tomita H; Osada S; Sugiyama Y; Adachi Y; Takami T
Cancer Sci; 2007 Mar; 98(3):416-23. PubMed ID: 17270031
[TBL] [Abstract][Full Text] [Related]
20. TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B-T cell axis and decreases tumour burden in murine fibrosarcoma.
Premkumar K; Shankar BS
Cancer Immunol Immunother; 2021 Jan; 70(1):153-168. PubMed ID: 32661685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
